©
2013 City of Hope
1500 East Duarte Road
Duarte, CA 91010
626-256-HOPE (4673)
1500 East Duarte Road
Duarte, CA 91010
626-256-HOPE (4673)
A National Cancer Institute-designated Comprehensive Cancer Center
388px
Pink Channel
The Pink Channel Delivers Hope
Time is precious for patients battling cancer.
We thank our partners at The Pink Channel and appreciate the support of their listeners who “pink” with us each day. As supporters of City of Hope, you are funding research that helps patients manage and ultimately conquer cancer and other life-threatening diseases. Together our efforts will save lives and improve the quality of life for patients and their families. Through your support, and the persistence and determination of City of Hope’s researchers, we can better understand the intricacies of cancer that will ultimately lead to its cure.
Every discovery we make and new treatment we develop gives patients the chance to live longer, better and more fully. This research is already making a difference around the world.
Join us in our mission to find a cure.
About City of Hope
Ranked as one of “America’s Best Hospitals” in cancer by U.S.News & World Report, City of Hope is a pioneer in the fields of hematopoietic cell transplantation and genetics. Designated as a comprehensive cancer center, the highest honor bestowed by the National Cancer Institute, City of Hope's research and treatment protocols advance care throughout the nation.
Learn more >>
City of Hope and Cancer
Discoveries happen at
City of Hope
because we foster an environment that supports intellectual creativity and freedom – the kind of thinking that enables us to redefine the future of medicine. With an urgency driven as much by compassion as intellectual curiosity, City of Hope has pioneered some of the most important scientific advances of the past century, including these research and treatment milestones:
A growing number of important cancer treatments used today are based onresearch pioneered by City of Hope scientists, including the drugs Herceptin, Rituxan, Avastin and Erbitux. This research continues each day with the hope of finding additional treatments aimed at finding a cure.
Last year, City of Hope conducted more than 300studiesenrolling more than 5,000 patients.Clinical trials allow patients to benefit from new treatments.
City of Hope surgeons were among the first to utilizerobotic technologyfor the treatment of cancer and are continually recognized as being leaders in number of procedures performed annually using this sophisticated technology.
An early pioneer inbone marrow transplantation, City of Hope has performed more than 8,600 bone marrow and stem cell transplants and maintains one of the largest, most successful programs of its kind in the world.
City of Hope researchers are expanding theirinvestigations of
aromatase inhibitor
s. The chemicals, which occur naturally in certain foods such as grapes and mushrooms, have been shown to slow the production of estrogen, which can stimulate the growth of breast cancer. Having demonstrated in the laboratory that someedible mushrooms, as well as red grape juice and other grape products, can suppress aromatase activity in breast cancer tumors, the research team is now working to isolate and identify the aromatase inhibiting substance in mushrooms.
City of Hope is studying the effectiveness of several new chemotherapy options for treating women with recurrentovarian cancer. City of Hope is collaborating with the National Cancer Institute on clinical trials of new ovarian cancer drugs.
City of Hope is actively conducting research to improve quality of life for breast cancer patients during treatment, rehabilitation and continuing care. These quality-of-life research efforts address the patient’s physical, psychological, social and spiritual well-being.
City of Hope is studying a type of lung cancer screening for smokers and former smokers in an effort to detect early signs of lung cancer in both women and men.
City of Hope’sSheri & Les Biller Patient and Family Resource Centerassists patients and families facing cancer and other life-threatening diseases. It is a uniquely comprehensive model that integrates and expands a wide range of important patient support services, including health education, psychological services, healing arts programs and end-of-life and bereavement care programs.
Donate onlinenow to support cancer research >>
Learn more about City of Hope >>
Learn more about City of Hope >>
For 100 years, we’ve been a global leader in the fight against cancer, diabetes, and HIV/AIDS. Hope powers our dream of curing diseases that affect millions of people worldwide. We need help from people like you. Become a Citizen of Hope, and join us in the fight to save lives all over the world.
Give to City of Hope
When you support City of Hope, you help us shorten the time it takes to get from bold, innovative ideas to powerful new medical treatments. Make a gift online now.
Connect with us on your favorite social networking and media sites! Show us you support our lifesaving research, treatment and education.
Ranked as one of “America’s Best Hospitals” in cancer by U.S.News & World Report, City of Hope is a pioneer in the fields of hematopoietic cell transplantation and genetics. Designated as a comprehensive cancer center, the highest honor bestowed by the National Cancer Institute, City of Hope's research and treatment protocols advance care throughout the nation.
NEWS & UPDATES
- Prostate cancer is the second-leading cause of cancer death among men in the United States, according to the American Cancer Society, and more than 29,000 will die of the disease this year alone. A new City of Hope study suggests those numbers could ultimately be brought down. In findings being presented today...
- Months after hearing the arguments and weeks before concluding its current session, the Supreme Court unanimously ruled that human genes are a product of nature and are not patentable. In the court’s majority opinion, Justice Clarence Thomas wrote: “A naturally occurring DNA segment is a product of...
- As City of Hope celebrates its 100th anniversary, we offer a four-part interview with Art Riggs, Ph.D., chair of the Department of Diabetes and Metabolic Diseases Research. Many of City of Hope’s best-known breakthroughs came through his lab. In this series, he casts an eye back to some of his greatest scientif...
- Patients struggling to overcome blood cancers face a wider threat than just the malignant cells menacing their bodies. They also face challenging — even life-threatening — treatment side effects. For many patients undergoing bone marrow transplantation, graft versus host disease (GVHD) ranks as one of the most ...
- Though endometrial cancer is the most common gynecological cancer, there are no screening tests for the disease and only limited treatments for women whose cancer isn’t eliminated through surgery or radiation. But new City of Hope research could ultimately pave the way both for targeted treatments and screening...
- For breast cancer patients whose disease has spread to local lymph nodes, treatment may entail surgical removal of those nodes to decrease the likelihood of recurrence. But that procedure also comes with the risk of lymphedema, a painful swelling of the arm caused by retained fluids. However, findings from a re...
- Understanding how cells repair DNA damage is key to revealing the role of BRCA1 and other tumor suppressors and to overcoming chemotherapy resistance in cancer. City of Hope research just published in Nucleic Acids Research sheds light on this topic and could lead to improved therapies. Principal investigator ...
- The discovery of genes that may increase a woman’s risk of developing breast cancer has resulted in potentially powerful tools to guide care – but like all new technologies, there’s a learning curve. Many physicians surveyed for a newly released City of Hope study said that, although they feel confident orderin...
- Smita Bhatia has watched pediatric patients defeat cancer, only to see many of them grow into adult survivors confronting new deadly opponents: secondary cancers and serious health problems resulting from the lifesaving but toxic therapies they received as children. Bhatia, M.D., M.P.H., is the Ruth Ziegler Cha...
- Our ability to maintain brain function and preserve learning and memory are at the core of City of Hope research just published in Molecular Cell Biology. Here, lead author Yanhong Shi, Ph.D., an associate professor in the departments of Neurosciences and Radiation Biology, explains the significance of her pape...
- Each year in the United States, lung cancer kills more people than colon, breast and prostate cancers combined. When the least dangerous form of skin cancer is taken out of the equation, lung cancer is the second most-common cancer in both men and women, after prostate and breast cancer respectively. It’s also ...
- As City of Hope celebrates its 100th anniversary, we offer a four-part interview with Art Riggs, Ph.D., chair of the Department of Diabetes and Metabolic Diseases Research. Many of City of Hope’s best-known breakthroughs came through his lab. In this series, he casts an eye back to some of his greatest scientif...
- The importance of applying sunscreen to reduce the risk of skin cancer has been drilled into the public for the past few decades. Yet studies have shown that skin cancer rates continue to climb, with melanoma diagnoses rising nearly 2 percent a year since 2000. What are people doing wrong? Skin cancer expert Vi...
- The first question after a diagnosis of prostate cancer: Is the cancer slow-growing or fast-growing? A slow-growing prostate cancer can simply be monitored, enabling patients to avoid potential side effects of treatment for as long as possible. A fast-growing cancer demands immediate attention, regardless of th...
- The annual meeting of the American Society for Clinical Oncology (ASCO) offers more than a way to highlight the numerous advances toward a cure for cancer. It also allows for reflection on barriers to quality research and optimal care. A briefing Friday focused on the impact of declining public funds for cancer...
